Bendamustine Accord 25mg/ml concentrate for solution for infusion - Important Safety Information from Accord Healthcare Ireland Ltd as approved by the HPRA (21.02.2023)

Notice type: 3rd Party Publications

Date: 27/02/2023




Problem Or Issue:

Important Safety Information from Accord Healthcare Ireland Ltd  regarding Bendamustine Accord 25mg/ml concentrate for solution for infusion - Potential risk of medication errors when diluting higher strength solution

Important Safety Information – Bendamustine Accord 25mg/ml concentrate for solution for infusion




« Back